×

Get the Prostate Cancer Patient Guide, available as a free emailed pdf.

Go here to learn more or to get a mailed copy.

Session 9: Combining Immunomodulatory Treatments for Prostate Cancer

Session 9: Combining Immunomodulatory Treatments for Prostate Cancer
29th Annual PCF Scientific Retreat: October 29, 2022 | 7:00 AM – 8:40 AM

Moderator: Nicholas Huntington, PhD
Monash University, Australia

Targeting P53 to Induce ICB Response in Cold Tumors
Nicholas Huntington, PhD
Monash University, Australia

Engaging FLT3 to Promote Dendritic Cell Expansion & Drive the Adaptive Anti-Tumor Immune Response
Michelle Kuhne, PhD
Gilead Sciences

Leveraging an Interplay Between Hormone Receptor Signaling and Immune Recognition to Enhance Immunotherapy in Prostate Cancer
Lisa Chesner, PhD
University of California, San Francisco

EZH2 Inhibition Reprograms the Tumor Microenvironment to Potentiate Response to Checkpoint Inhibition
Leigh Ellis, PhD
Cedars Sinai Medical Center

 

80 cents of every dollar donated goes to our prostate cancer research mission

Join the fight against prostate cancer today. Donate